Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/9544
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Minov, JB | en_US |
dc.contributor.author | Karadzinska-Bislimovska, J | en_US |
dc.contributor.author | Petrova T | en_US |
dc.contributor.author | Vasilevska, K | en_US |
dc.contributor.author | Stoleski, S | en_US |
dc.contributor.author | Mijakoski, D | en_US |
dc.date.accessioned | 2020-11-23T21:18:20Z | - |
dc.date.available | 2020-11-23T21:18:20Z | - |
dc.date.issued | 2017-01-27 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12188/9544 | - |
dc.description.abstract | Objective: To assess efficacy and safety of inert cellulose powder (ICP) in the treatment of mild seasonal allergic rhinitis (SAR). Methods: An observational, non-randomized, open study including 74 examinees suffering from mild SAR was conducted. The study subjects were divided in two groups, Group 1 (G1) and Group 2 (G2). The study subjects from G1 were treated 10 days with oral cetirizine and ICP, while the study subjects from G2 were treated 10 days only with oral cetirizine. The treatment outcomes were evaluated after five and 10 days by self-assessment of the symptoms on a five-point scale. Results: In both groups improvement of the symptoms five and 10 days after the treatment was registered. There was significantly higher prevalence of the G1 study subjects in the point 4 (“major relief, casual sneezing”) five days after beginning of the treatment (43.2% vs. 18.9%; P<0.05), as well as in the point 5 (“complete relief, without symptoms”) at the end of the treatment (56.7% vs. 27.0%; P<0.05). A low frequency of adverse effects was registered among examinees of both groups. Conclusion: The results obtained indicated high efficacy and safety of ICP in the treatment of mild SAR. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Sunnyvale, Calif. : OMICS Pub. Group | en_US |
dc.relation.ispartof | Journal of Pulmonary & Respiratory Medicine | en_US |
dc.subject | Efficacy | en_US |
dc.subject | Inert cellulose powder | en_US |
dc.subject | Seasonal allergic rhinitis | en_US |
dc.subject | Safety | en_US |
dc.subject | Cethirizine | en_US |
dc.title | Inert Cellulose Powder in the Treatment of Seasonal Allergic Rhinitis | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.4172/2161-105X.1000388 | - |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
Appears in Collections: | Faculty of Medicine: Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Inert Cellulose Powder in the Treatment of Seasonal Allergic Rhinitis.pdf | 425.34 kB | Adobe PDF | View/Open |
Page view(s)
95
checked on Apr 30, 2024
Download(s)
22
checked on Apr 30, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.